Chronic hepatitis B virus infection in patients with normal" ALT levels"

被引：5

作者：

Hoda K. ^{[1
]}

Nguyen M.H. ^{[1
]}

机构：

[1] Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA 94304-1509

来源：

Current Hepatitis Reports | 2007年 / 6卷 / 1期

关键词：

Chronic Hepatitis; Basal Core Promoter; HBeAg Status; HBeAg Positivity;

D O I：

10.1007/BF02942175

中图分类号：

学科分类号：

摘要：

Not many data exist to guide us in the management of patients with chronic hepatitis B virus infection and normal" alanine aminotransferase levels. Many of these patients may not have normal levels on long-term follow-up or when the upper limit of normal is determined from a truly healthy reference population. These patients may have significant histologic disease and benefit from further investigation or treatment. This article focuses on the disease course of such patients. Copyright © 2007 by Current Medicine Group LLC."

引用

页码：24 / 29

页数：5

共 50 条

[41]

Wang C., Deubner H., Shuhart M., Et al., High prevalence of significant fibrosis in patients with immunotolerance to chronic hepatitis B infection [abstract], Hepatology, 42, (2005)

[42]

Park H.H., Song I.H., Chung Y.H., Et al., Chronic hepatitis B in hepatocarcinogenesis, Postgrad Med J, 82, pp. 507-515, (2006)

[43]

Beasley R.P., Hepatitis B virus as the etiologic agent in hepatocellular carcinoma, Hepatology, 2, SUPPL., (1982)

[44]

Sakuma K., Saitoh N., Kasai M., Et al., Relative risks of death due to liver disease among Japanese male adults having various statuses for hepatitis B s and e antigen/antibody in serum: A prospective study, Hepatology, 8, pp. 1642-1646, (1988)

[45]

Beasley R.P., Hwang L.Y., Lin C.C., Chien C.S., Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan, Lancet, 2, 8256, pp. 1129-1133, (1981)

[46]

Bruix J., Sherman M., Practice Guidelines Committee, American Association for the Study of Liver Diseases: Management of hepatocellular carcinoma, Hepatology, 42, pp. 1208-1236, (2005)

[47]

Sherman M., Peltekian K.M., Lee C., Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: Incidence and prevalence of hepatocellular carcinoma in a North American urban population, Hepatology, 22, pp. 432-438, (1995)

[48]

Van Thiel D.H., Gavaler J.S., Wright H., Tzakis A., Liver biopsy. Its safety and complications as seen at a liver transplant center, Transplantation, 55, pp. 1087-1090, (1993)

[49]

Bravo A.A., Sheth S.G., Chopra S., Liver biopsy, N Engl J Med, 344, pp. 495-500, (2001)

[50]

McGill D.B., Rakela J., Zinsmeister A.R., Ott B.J., A 21-year experience with major hemorrhage after percutaneous liver biopsy, Gastroenterology, 99, pp. 1396-1400, (1990)

← 1 2 3 4 5 →